Used in pharmaceutical research as a potent and selective inhibitor of kinases involved in inflammatory and oncogenic signaling pathways. Shows promise in the development of targeted cancer therapies, particularly for tumors driven by dysregulated kinase activity. Also investigated for autoimmune disease treatment due to its ability to modulate immune cell function. Its structure allows for high binding affinity to specific ATP-binding sites in target proteins, enhancing therapeutic precision. Commonly employed in preclinical studies to evaluate pathway inhibition and antiproliferative effects in cell cultures and animal models.